找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Immunotherapeutic Prospects of Infectious Diseases; K. Noel Masihi,Werner Lange Conference proceedings 1990 Springer-Verlag Berlin, Heidel

[复制链接]
楼主: sprawl
发表于 2025-3-25 04:43:18 | 显示全部楼层
Immunotherapeutic Prospects of Infectious Diseases978-3-642-76120-1
发表于 2025-3-25 09:58:24 | 显示全部楼层
发表于 2025-3-25 13:24:56 | 显示全部楼层
发表于 2025-3-25 19:06:34 | 显示全部楼层
发表于 2025-3-25 20:42:49 | 显示全部楼层
receptor immunoassays is the prediction of response to endocrine therapy and assessment of prognosis (disease-free interval and survival). The clinical utility of ER and PR steroid-binding assays (SBA) for evaluating these parameters in patients with advanced breast cancer has been well documented (
发表于 2025-3-26 00:44:14 | 显示全部楼层
D. Trizio,A. M. Isetta,G. F. Doria,M. C. Fornasiero,M. Ferrari,R. Ferreccio,P. Carminati,R. Roncuccieasure of the amount of analyte originally present. For theroetical and practical reasons this type of assay was not widely accepted and a variant of the basic system became more popular. This is the so-called two-site immunoradiometric assay (Woodhead et al, 1974) in which antigen is bound by label
发表于 2025-3-26 04:32:03 | 显示全部楼层
发表于 2025-3-26 08:33:57 | 显示全部楼层
S. Kotani,A. Nagao,T. Tamura,H. Okamura,A. Nagata,K. Aoyama,S. Kusumoto,S. Kokeguchi,K. Kato,N. Fujimated new cases in the USA for 2017 are 56,870 individuals. Out of them about 2275 (4%) will have distant metastasis. From them about 1150 will not survive until 2022. Even though we do not have exact numbers, the same situation should be in Europe. In other parts of the world, given the situation t
发表于 2025-3-26 15:00:43 | 显示全部楼层
W. G. Bessler,B. Kleine,L. Biesert,S. Schlecht,R. Schaude,K-H. Wiesmüller,J. Metzger,G. Jungied both to perspective and peri-therapy dosimetry, depending on the goal and the available resources; since it improves awareness in taking a decision in patient’s management, it represents a powerful instrument to support clinical strategies aimed at improving safety and efficacy of treatments.
发表于 2025-3-26 20:06:23 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-18 08:48
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表